Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May;28(5):268-73.
doi: 10.1089/apc.2013.0356. Epub 2014 Apr 17.

The centrality of laboratory services in the HIV treatment and prevention cascade: The need for effective linkages and referrals in resource-limited settings

Affiliations
Review

The centrality of laboratory services in the HIV treatment and prevention cascade: The need for effective linkages and referrals in resource-limited settings

George Alemnji et al. AIDS Patient Care STDS. 2014 May.

Abstract

Strong laboratory services and systems are critical for delivering timely and quality health services that are vital to reduce patient attrition in the HIV treatment and prevention cascade. However, challenges exist in ensuring effective laboratory health systems strengthening and linkages. In particular, linkages and referrals between laboratory testing and other services need to be considered in the context of an integrated health system that includes prevention, treatment, and strategic information. Key components of laboratory health systems that are essential for effective linkages include an adequate workforce, appropriate point-of-care (POC) technology, available financing, supply chain management systems, and quality systems improvement, including accreditation. In this review, we highlight weaknesses of and gaps between laboratory testing and other program services. We propose a model for strengthening these systems to ensure effective linkages of laboratory services for improved access and retention in care of HIV/AIDS patients, particularly in low- and middle-income countries.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Different stages of the HIV Treatment and Prevention Cascade. It starts from HIV diagnosis to CD4 measurement for clinical staging and determination of eligibility for ART. This is followed by monitoring for efficacy and safety of treatment through measurement of chemistry, hematology, and CD4 parameters, and opportunistic infections testing. The final stage involves measurement of viral load to determine outcome of treatment and follow up HIV drug resistance testing for patients failing therapy.

References

    1. WHO HIV/AIDS. Fact sheet No 360. [Accessed August 26, 2013]; Available at: http://www.who.int/mediacentre/factsheets/fs360/en/index.html.
    1. UNAIDS. World AIDS day report 2012: results. [Accessed June 24, 2013]; Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiolo....
    1. Marum E, Taegtmeyer M, Parekh B, et al. “What took you so long?” The impact of PEPFAR on the expansion of HIV testing and counseling services in Africa. J Acquir Immune Defic Syndr. 2012;60:S63–S69. - PubMed
    1. Nglazi MD, Kaplan R, Wood R, Bekker LG, Lawn SD. Identification of losses to follow-up in a community-based antiretroviral therapy clinic in South Africa using a computerized pharmacy tracking system. BMC Infect Dis. 2010;10:329. - PMC - PubMed
    1. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: A systematic review. PLoS Med. 2011;8:1–16. - PMC - PubMed

Publication types

MeSH terms

Substances